PFS
ROIV icon

Prospera Financial Services’s Roivant Sciences ROIV Stock Holding History

Prospera Financial Services’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,276
Closed -$21K – 2397
2022
Q1 		$21K Buy
+4,276
New +$28.2K ﹤0.01% 1721

Other funds holding ROIV

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
PT
Palantir Technologies Denver, Colorado $9.72M AUM 6.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return

Prospera Financial Services's ROIV Position: Q2 2022 in Review

Prospera Financial Services sold out of Roivant Sciences (ROIV) in Q2 2022, closing a stake of 4,276 shares — an estimated $21K sold.

Prospera Financial Services first reported a position in ROIV in Q1 2022 and held it in 1 quarter. The position peaked at $21K in Q1 2022. 71 funds tracked by Wall St. Rank hold ROIV as of Q2 2022.

  • Prospera Financial Services reported no remaining Roivant Sciences position as of Q2 2022 after selling out during the quarter.
  • Prospera Financial Services sold 4,276 Roivant Sciences shares in Q2 2022, an estimated $21K.
  • Prospera Financial Services first reported a position in Roivant Sciences in Q1 2022 and held it in 1 quarter.
  • Prospera Financial Services's Roivant Sciences position peaked at $21K in Q1 2022.
  • 71 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2022.

Based on Prospera Financial Services's 13F filing for Q2 2022, filed 8 Aug 2022.